Driven by GLP-1s, pharma’s relationship with consumers is starting to change

The rise of direct-to-consumer channels, driven largely by consumer willingness to pay for GLP-1s for weight loss without using insurance, is leading to new arrangements between pharmaceutical companies and employers that oversee healthcare coverage for their employees.

Raccontata daendpoints.news